Lördag 28 December | 05:18:18 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-05-23 08:30 Kvartalsrapport 2025-Q1
2025-05-21 N/A Årsstämma
2025-02-28 08:30 Bokslutskommuniké 2024
2024-11-05 - Kvartalsrapport 2024-Q3
2024-08-30 - Kvartalsrapport 2024-Q2
2024-08-29 - Split CMH 500:1
2024-05-24 - Kvartalsrapport 2024-Q1
2024-05-20 - X-dag ordinarie utdelning CMH 0.00 SEK
2024-05-15 - Årsstämma
2024-03-22 - Bokslutskommuniké 2023
2024-01-26 - Extra Bolagsstämma 2024
2023-11-01 - Kvartalsrapport 2023-Q3
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-25 - Kvartalsrapport 2023-Q1
2023-04-14 - X-dag ordinarie utdelning CMH 0.00 SEK
2023-02-28 - Bokslutskommuniké 2022
2022-12-13 - Extra Bolagsstämma 2022
2022-11-18 - Kvartalsrapport 2022-Q3
2022-08-30 - Kvartalsrapport 2022-Q2
2022-05-27 - Kvartalsrapport 2022-Q1
2022-04-26 - X-dag ordinarie utdelning CMH 0.00 SEK
2022-04-25 - Årsstämma
2022-02-25 - Bokslutskommuniké 2021
2021-10-25 - Kvartalsrapport 2021-Q3
2021-10-05 - Extra Bolagsstämma 2021
2021-08-30 - Kvartalsrapport 2021-Q2
2021-05-27 - Kvartalsrapport 2021-Q1
2021-04-16 - X-dag ordinarie utdelning CMH 0.00 SEK
2021-04-15 - Årsstämma
2021-02-26 - Bokslutskommuniké 2020
2020-11-20 - Kvartalsrapport 2020-Q3
2020-08-18 - Extra Bolagsstämma 2020
2020-08-07 - Kvartalsrapport 2020-Q2
2020-04-29 - Kvartalsrapport 2020-Q1
2020-04-24 - X-dag ordinarie utdelning CMH 0.00 SEK
2020-04-23 - Årsstämma
2020-02-28 - Bokslutskommuniké 2019
2019-11-11 - Kvartalsrapport 2019-Q3
2019-08-30 - Kvartalsrapport 2019-Q2
2019-05-24 - Kvartalsrapport 2019-Q1
2019-05-10 - X-dag ordinarie utdelning CMH 0.00 SEK
2019-05-09 - Årsstämma
2019-02-28 - Bokslutskommuniké 2018
2018-11-16 - Kvartalsrapport 2018-Q3
2018-08-31 - Kvartalsrapport 2018-Q2
2018-05-25 - Kvartalsrapport 2018-Q1
2018-04-27 - X-dag ordinarie utdelning CMH 0.00 SEK
2018-04-26 - Årsstämma
2018-02-28 - Bokslutskommuniké 2017
2017-10-31 - Kvartalsrapport 2017-Q3
2017-08-31 - Kvartalsrapport 2017-Q2
2017-04-28 - Kvartalsrapport 2017-Q1
2017-04-20 - X-dag ordinarie utdelning CMH 0.00 SEK
2017-04-19 - Årsstämma
2017-02-10 - Bokslutskommuniké 2016

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Chordate Medical Holding är ett medicintekniskt bolag som har utvecklat, patenterat och CE-märkt en nervmodulerande behandlingsteknik för kronisk migrän och kronisk nästäppa (rinit), Kinetic Oscillation Stimulation (K.O.S). Bolaget säljer produkter till behandlande kliniker på utvalda europeiska marknader, Israel samt Saudiarabien, med målsättningen att öka närvaron på den globala marknaden.
2024-03-11 11:18:00

A new Italian scientific case report, from a team at Campus Bio-Medico in Rome, detailing the Chordate treatment method Ozilia, reports on a 60-year-old male patient whose days with migraines decreased significantly, from 18 to 7 days per month, with a simultaneous significant reduction in pain level. The case report was recently published in the prestigious scientific journal Cephalalgia Reports.

"This is another example of a patient who does not respond to, or no longer receives benefit from, common medications for chronic migraines, but where Ozilia treatment appears to have worked well," says Anders Weilandt, CEO of Chordate. Weilandt adds that it should be noted that this does not refer to the expected publication of Chordate's significant migraine study PM007.

The report indicates that pain relief and reduction of migraine days from the initial treatment period had a sustained effect. After about three months, the patient underwent another treatment period with Ozilia, resulting in a quicker and more significant response:

"The preliminary results confirm that KOS treatment is effective both in relieving acute pain and reducing attack frequency. Although the precise mechanism by which KOS modulates the trigeminal-autonomic reflex is still speculative, it could be a viable alternative to the treatment of resistant and refractory chronic migraine, when other approved treatments have been shown to be ineffective or poorly tolerated," the authors write in the conclusion of the report.

The report, Extended regular use of kinetic oscillation stimulation (KOS) in refractory chronic migraine: case report of a first, single-subject experience, was authored by a group of doctors and researchers under the leadership of Professor Fabrizio Vernieri, Director of Headache and Neurosonology at Bio-Medico Campus University Hospital in Rome.

Read the full report